This website uses cookies. By using the site you are agreeing to our Privacy Policy.

Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.

Main menu starts here.
Skip the main menu to current location in your website.

Current location in your website.
Skip to main contents.


1968 December the 5th Founded as a joint venture between Daiichi Seiyaku Group and U. S. Mallinckrodt
1972 Started local production of Ultra-Techne Kow Installed hot cells
1978 Completed construction of Chiba Plant Celebrated the 10th anniversary of the company.
1979 Installed a large computer
1983 Celebrated the 15th anniversary of the company
1984 Installed a cyclotron
1988 Celebrated the 20th anniversary of the company Dissolved the joint venture with Mallinckrodt and became 100% affiliate of Daiichi Seiyaku
1990 Awarded a prize from Science and Technology Agency Minister for radiation safety control (Chiba Plant)
1991 Installed the second cyclotron
1993 Celebrated the 25th anniversary of the company
1995 Awarded a prize from Kanto International Trade and Industry Director General for a superior production facility with tree-planting (Chiba Plant)
1998 Celebrated the 30th anniversary of the company
2000 Started the sale of immunodiagnostic products through TFB, Inc.
2001 Obtained a certificate of [ISO14001] for Chiba Office
2002 Approval of Iofetamine (¹²³I) [Daiichi]
2003 Celebrated the 35th anniversary of the company
2004 Transferred Immunodiagnostic business to TFB, Inc.
2005 Installed the third cyclotron
2006 Became 100% subsidiary of FUJIFILM Corporation in Oct.
2007 FUJIFILM RI Pharma Co., Ltd., New Company started in April.
2008 Celebrated the 40th anniversary of the company
2010 Started the sale of Resovist transferred from Bayer
2015 Approval of ADENOSINE Injection Syringe FRI
Approval of Octreoscan® Injection
2016 Kawasaki PET Laboratory established
Ibaraki PET Laboratory established
Approval of Amyvid®
2017 Approval of Fludeoxyglucose (18F) Injection FRI

Footer starts here.

Pages ends here.
Move to top of the page.